Clinical relevance of all-trans retinoic acid pharmacokinetics and its modulation in acute promyelocytic leukemia

Leukemia and Lymphoma

Volumn 23, Issue 5-6, 1996, Pages 539-543

  Lazzarino, Mario ^a   Regazzi, Mario B ^a   Corso, Alessandro ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Acute promyelocytic leukemia; All trans retinoic acid

Indexed keywords

ALPHA INTERFERON; ANTHRACYCLINE; CYTOCHROME P450; DRUG METABOLIZING ENZYME; KETOCONAZOLE; LIPOSOME; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; AREA UNDER THE CURVE; CANCER COMBINATION CHEMOTHERAPY; CELL DIFFERENTIATION; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG METABOLISM; ENZYME INHIBITION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW;

EID: 0030468010     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054862     Document Type: Review

References (45)

1. Lippman, S. M , Kessler, J. F., Meyskens, F. L. (1987) Retinoids as preventive and therapeutic anticancer agents I. Cancer Treat. Rep., 71, 391-405.
2. Lippman, S. M., Kessler, J. F., Meyskens, F. L. (1987) Retinoids as preventive and therapeutic anticancer agents II. Cancer Treat. Rep., 71, 493-515.
3. Pemrick, S. M., Lucas, D. A., Grippo, J F. (1994) The retinoid receptors. Leukemia, 8, 1797-1806
4. Grignani, F., Fagioli, M., Alcalay, M., Longo, L., Pandolfi, P. P., Donti, E., Biondi, A., Lo Coco, F., Grignani, F., Pelicci, P. G. (1994) Acute promyelocytic leukemia, from genetics to treatment. Blood, 83, 10-25.
5. Alcalay, M., Zangrilli, D., Fagioli, M., Pandolfi, P. P., Mercarelli, A., Lo Coco, F., Biondi, A., Grignani, F., Pelicci, P. G. (1992) Expression patterns of the Rar-alfa-PML function gene in acute promyelocytic leukemia. PNAS, 89, 4840-46.
6. Huang, M. E , Ye, Y. C., Chen, S. R., Chai, J. R., Lu, J. X., Zhoa, L., Gu, L. J , Wang, Z. Y. (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72, 567-572.
7. Castaigne, S., Chomienne, C., Daniel, M. T., Ballerini, P., Berger, R., Fenaux, P , Degos, L. (1990) All-trans retinoic acid as differentiation therapy for acute promyelocytic leukemia. Blood, 76, 1704-1709.
8. Warrell, R. P., Frankel, S. R., Miller, W. H , Scheinberg, D. A., Itri, L. M., Hittelman, W N., Vyas, R., Andreff, M., Tafuri, A., Jakubowski, A., Gabrilove, J , Gordon, M. S., Dmitrovsky, E. (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N. Engl. J. Med., 324, 1385-1393.
9. Chen, Z. X., Xue, Y. Q., Zhang, R , Tao, R. F., Xia, X. M., Li, C., Wang, W., Zu, W. Y., Yao, X. Z., Ling, B. J. (1991) A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood, 78, 1413-1419.
10. Muindi, J., Frankel, S. R., Miller, W. H., Jakubowsky, A., Scheinberg, D. A., Young, C. W., Dmitrowsky, E., Warrel, R. P. (1992) Continuous treatment with all-trans retinoic acid results in a progressive decrease in plasma concentrations, implications for relapse and retinoid "resistance" in acute promyelocytic leukemia. Blood, 79, 299-303.
11. Warrell, R. P. (1993) Retinoid resistance in acute promyelocytic leukemia: new mechanisms, strategies, and implications. Blood, 82, 1949-1953.
12. Tallman, M. S. (1994) All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematological malignancies. Sem. Hematol., 31, Suppl. 5, 38-48.
13. Fenaux, P. (1994) Results of APL 91 european trial combining ATRA and chemotherapy: presentation of APL 1993 trial. Leukemia, 8, Suppl. 3, S70-S72.
14. Lo Coco, F., Diverio, D., Avvisati, G., Luciano, A., Biondi, A., Mandelli, F. (1995) High frequency of early molecular remission in acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (Italian GIMEMA-AIEOP "AIDA" trial). Blood, 86, No. 10, Suppl. 1, 265a.
15. Brazzel, R., Vane, F., Ehmann, C. (1983) Pharmacokinetics of isotretinoin during repetitive dosing to patients. J. Clin. Oncol., 11, 59-66.
16. Blaner, W. S. (1993) Biochemistry and pharmacology of retinoids. In: Waun Ki Hong, Reuben Lotan, eds. Retinoids in Oncology, p 1-42. Marcel Dekker, N.Y.
17. Fiorella, P. D., Napoli, J. L. (1994) Microsomal retinoic acid metabolism. J. Biol. Chem., 269, 10538-10544.
18. Adamson, P. C. (1994) Pharmacokinetics of all-trans-retinoic acid: clinical implications in acute promyelocytic leukemia. Seminars in Hematology, 31, suppl. 5, 14-17.
19. Adamson, P. C. (1994) Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer. Leukemia, 8, 1813-1816.
20. Muindi, J. R., Frankel, S. R., Huselton, C., DeGrazia, F., Garland, W. A., Young, C W., Warrel, R. P. (1992) Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res., 52, 2138-2142.
21. Muindi, J. F., Young, C. W. (1993) Lipid hydroperoxides greatly increase the rate of oxidative catabolism of all-trans retinoic acid by human cell culture microsomes genetically enriched in specified cytochrome P-450 isoforms. Cancer Res., 53, 1226-1229.
22. Boylan, J. F., Gudas, L. J. (1991) Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in a reduction in differentiation specific gene expression in F9 teratocarcinoma cells. J. Cell. Biol., 111, 965-970.
23. Cornic, M., Delva, L., Guidez, F., Balitrand, N., Degos, L., Chomienne, C. (1992) Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients. Cancer Res., 52, 3329-3334.
24. Adamson, P. C., Boylan, J. F., Balls, F. M., Murphy, R. F., Godwwin, K. A., Gudas, L. J., Poplack, D. G. (1993) Time course of induction of metabolism of all-trans-retinoic acid and the up-regulation of cellular retinoic acid-binding protein (CRABP). Cancer Res., 53, 472-476.
25. Estey, E., Cabanillas, F , Rosenblum, M., Kurzrock, R., Bole, J., Andreeff, M , Keating, M., Kantarjian, H., Lopez-Berenstein, G. (1994) Phase I and pharmacology study of liposomal all-trans retinoic acid. Blood, 84, Suppl. 1, 380a.
26. Roberts, A. B. (1981) Microsomal oxidation of retinoic acid in hamster liver, intestine and testis. Ann N Y Acad. Sci., 359, 45-53.
27. Bossche, H. V., Willemsens, G. (1991) Retinoic acid and cytochrome P-450. In Saurat JH (ed): Retinoids: 10 years on. Karger, Basel, p 79-88.
28. Van Wauwee, J. P., Coene, M. C., Goossens, J., Cools, W., Monbaliu, J. (1990) Effects of cytocrhome P-450 inhibitors on the in vivo metabolism of all-trans retinoic-acid in rats. J. Pharmacol. Exp. Ther., 252, 365-369.
29. Rigas, J R., Francis, P. A., Muindi, J. R. F., Kris, M. G., Huselton, C., DeGrazia, F., Orazem, J. P., Young, C. W., Warrell, R. P. (1993) Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans retinoic acid, and its modulation by ketoconazole. J. Natl Cancer Inst., 85, 1921-1926.
30. Lee, J. S., Newman, R. A., Lippman, S. M., Fossella, F. B., Calayag, M., Raber, M. N., Krakoff, I. H., Hong, W. K. (1995) Phase I evaluation of all-trans retinoic acid with and without ketoconazole in adulte with solid tumors. J. Clin. Oncol., 13, 1501-1508.
31. 2) in acute promyelocytic leukemia. Blood, 82, 3560-3563.
32. Bailey, J., Pluda, J. M., Foli, A., Saville, M. W., Bauza, S., Adamson, P. C., Murphy, R. F., Cohen, R. B., Broder, S., Yarchoon, R. (1995) Phase I/II study of intermittent all-trans-retinoic acid alone and in combination with interferon alfa-2a, in patients with epidemic Kaposi's sarcoma J. Clin. Oncol., 13, 1966-1974.
33. Adamson, P. C., Bailey, J., Pluda, J., Poplack, D. G., Bauza, S., Murphy, R. R, Yarchoan, R., Balis, F. M. (1995) Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule. J. Clin. Oncol., 13, 1238-1240.
34. Borden, E. C. (1992) Interferons expanding therapeutic roles. N. Engl. J. Med., 226, 1491-1493.
35. Hemmi, H., Breitman, T. (1987) Combinations of recombinant human interferons and retinoic acid synergistically induce differentiation of the human promyelocytic leukemia cell line HL-60. Blood, 69, 501-507.
36. Bollag, W. (1991) Retinoids and interferon: a new promising combination? Br. J. Haematol., 79, Suppl. 1, 87-91.
37. Lippman, S. M., Glisson, B. S., Kavanagh, J. J., Lotan, R., Hong, W. K., Paredes-Espinoza, M., Hittelman, W. N., Holdener, E. E., Krakoff, I. H. (1993) Retinoic acid and interferon combination studies in human cancer. Eur. J. Cancer, 29A, S9-S13.
38. Moore, D. M., Kalvakolanu, D. V., Lippman, S. M., Kavanagh, J. J., Hong, W. K., Borden, E. C., Paredes-Espinoza, M., Krakoff, I. H. (1994) Retinoic acid and interferon in human cancer: mechanistic and clinical studies. Sem. Hematol., 31, Suppl. 5, 31-37.
39. Okuno, H , Kitao, Y., Takasu, M., Kano, H., Kunieda, K., Seki, T., Shizaki, Y., Sameshima, Y. (1990) Depression of drug metabolizing activity in the human liver by interferon α. Eur. J. Clin. Pharmacol., 39, 365-367.
40. Israel, B. C., Blouin, R. A., McIntyre, W., Shedlofsky, S. I. (1993) Effect of interferon a monotherapy on hepatic drug metabolism in cancer patients. Br. J. Clin. Pharmacol., 36, 229-235.
41. Lazzarino, M., Corso, A., Regazzi, M. B., Iacona, I., Bernasconi, C. (1995) Modulation of all-trans retinoid acid pharmacokinetics in acute promyelocytic leukemia by prolonged interferon-α therapy. Br. J. Haematol., 90, 928-930.
42. Koller, E., Krieger, O., Kasparu, H., Lutz, D. (1991) Restoration of all-trans retinoic acid sensitivity by interferon in acute promyelocytic leukemia. Lancet, 338, 1154-1155 (Letter).
43. Warrell, R. P. (1993) Retinoid resistance. Lancet, 341, 126 (Letter).
44. Dermime, S., Grignani, F., Monica, C , Nervi, C., Sozzi, G., Talamo, G. P., Marchesi, E , Formelli, F., Parmiani, G., Pelicci, P. G., Gambacorti-Passerini, C. (1993) Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the PML/RARα protein. Blood, 82, 1573-1577.
45. Agadir, A., Comic, M., Lefebvre, P., Gourmel, B., Bahtrand, N., Degos, L., Chomienne, C. (1995) Differential uptake of all-trans retinoic acid by acute promyelocytic leukemic cells, evidence for its role in retinoic acid efficacy Leukemia, 9, 139-145.